Citation Impact
Citing Papers
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter
2012
Osteoporosis
2019 Standout
Osteoporosis Prevention and Treatment
1996
High Prevalence of Vitamin D Inadequacy and Implications for Health
2006 Standout
Rett Syndrome - an update
2003
Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>
1999 Standout
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
The Role of Calcitonin in the Development and Treatment of Osteoporosis*
1987
Comparison of four different protocols of I-131 therapy for treating single toxic thyroid nodule
2008
Effects of DeflazacortVersusPrednisone on Bone Mass, Body Composition, and Lipid Profile: A Randomized, Double Blind Study in Kidney Transplant Patients1
1998
Pathogenesis of osteoporosis
2003
Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
2003 Standout
Hürthle cell Thyroid Carcinoma Presenting as A “Hot” Nodule
2011
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
2017
VI. Meta-Analysis of Calcitonin for the Treatment of Postmenopausal Osteoporosis
2002
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Vitamin D Deficiency
2007 Standout
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
2006 Standout
Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women
1992 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Effect of calcitonin on bone mass and fracture rates
1991
Skeletal remodeling in health and disease
2007 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen
1992
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Effects of Tamoxifen on Bone Mineral Density in Postmenopausal Women with Breast Cancer
1992
Calcitriol Treatment Is Not Effective in Postmenopausal Osteoporosis
1989
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Vitamin D3and Calcium to Prevent Hip Fractures in Elderly Women
1992 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Estrogen Preserves a Normal Intestinal Responsiveness to 1,25-Dihydroxyvitamin D3in Oophorectomized Women*
1990
Production and Actions of Estrogens
2002 Standout
Glucocorticoid-induced osteoporosis
2000
Frailty in elderly people
2013 Standout
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
2009
Prevention of falls and consequent injuries in elderly people
2005 Standout
The impact of hyperfiltration on the diabetic kidney
2014
Treatment of Postmenopausal Osteoporosis with Calcitriol or Calcium
1992
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: Comparison with normal postmenopausal women
1990
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum
2017 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Involutional Osteoporosis
1986 Standout
Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro
1997 Standout
Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene
2002
Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
2000 Standout
Biochemical Markers of Bone Turnover for the Clinical Assessment of Metabolic Bone Disease
1990
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
2001 Standout
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
TREATMENT OF OSTEOPOROSIS
1995
Diabetic Kidney Disease
2017 Standout
VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women
2002
Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial
2006
Treatment of osteoporosis.
1967
Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
2014
Radioiodine Therapy in Benign Thyroid Diseases: Effects, Side Effects, and Factors Affecting Therapeutic Outcome
2012
Efficiency of radioactive I-131 therapy in geriatric patients with toxic nodular goiter.
2012
Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
1996
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Calcium nutrition and bone health in the elderly
1982
American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi Medical Guidelines for Clinical Practice for the Diagnosis and Management of Thyroid Nodules - 2016 Update Appendix
2016 Standout
Biochemical markers of bone turnover in osteoporosis.
1997
Early Postmenopausal Bone Loss is Not Associated with a Decrease in Circulating Levels of 25-Hydroxyvitamin D, 1,25-Dihydroxyvitamin D, or Vitamin D-Binding Protein*
1987
Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids
1984
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
2006
Addressing unmeasured confounding in comparative observational research
2018 StandoutNobel
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis
2005
The bone-remodeling transient: Implications for the interpretation of clinical studies of bone mass change
1994
Bone metabolism and disease in chronic kidney disease
2003
Mineral metabolism in Turner's syndrome: evidence for impaired renal vitamin D metabolism and normal osteoblast function.
1992
Population-Based Study of Age and Sex Differences in Bone Volumetric Density, Size, Geometry, and Structure at Different Skeletal Sites
2004 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of A Vattimo being referenced
Brain perfusion abnormalities in Rett syndrome
1997
Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism
2006
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.
1988
Prevalence of Glomerular Hyperfiltration and Nephromegaly in Normo- and Microalbuminuric Type 2 Diabetic Patients
1993
Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
1984
The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis
1984
EFFECTS OF 1,25‐DIHYDROXYCHOLECALCIFEROL ON 47CALCIUM ABSORPTION IN POST‐MENOPAUSAL OSTEOPOROSIS
1979
Vitamin D Metabolites in Postmenopausal Osteoporosis
1984
[Therapeutic effect of synthetic calcitonin from salmon in Paget's disease and in osteoporosis].
1977
Effects of a new glucocorticoid, oxazacort, on some variables connected with bone metabolism in man: a comparison with prednisone.
1977
Synthetisches Human-Calcitonin bei Osteodystrophia deformans (Paget) und Osteoporose
2008
Hürthle cell tumor dwelling in hot thyroid nodules: preoperative detection with technetium-99m-MIBI dual-phase scintigraphy.
1998